Bio-Techne Corporation (BVMF:T1CH34)

Bio-Techne Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	144.96	162.19	151.79	180.57	172.57	199.09
Short-Term Investments	-	-	1.07	23.74	74.46	32.46
Cash & Short-Term Investments	144.96	162.19	152.86	204.31	247.03	231.55
Cash Growth	-22.70%	6.10%	-25.18%	-17.29%	6.68%	-14.52%
Receivables	183.9	206.88	241.39	218.47	194.55	145.39
Inventory	203.19	189.45	179.73	171.64	141.12	116.75
Other Current Assets	77.46	49.79	43.43	27.07	22.86	16.92
Total Current Assets	609.51	608.3	617.42	621.48	605.56	510.61
Property, Plant & Equipment	311.06	319.12	342.44	324.53	288.8	281.74
Long-Term Investments	258.61	253.83	252.15	272.71	36.03	0.28
Goodwill	978.91	980.94	972.66	872.74	822.1	843.07
Other Intangible Assets	350.11	365.6	507.08	534.65	531.52	615.97
Long-Term Deferred Tax Assets	-	10.31	-	-	-	-
Other Long-Term Assets	17.96	19.78	12.12	12.59	10.8	11.3
Total Assets	2,526	2,558	2,704	2,639	2,295	2,263
Accounts Payable	30.16	25.31	37.97	25.68	33.87	29.38
Accrued Expenses	62.78	90.35	74.7	51.63	79.84	66.58
Current Portion of Long-Term Debt	-	-	-	-	12.98	13.28
Current Portion of Leases	13.77	14.1	12.92	11.2	11.93	11.6
Current Income Taxes Payable	2.85	10.77	3.71	12.02	13.24	5.34
Current Unearned Revenue	30.45	32.57	27.93	23.07	23.41	19
Other Current Liabilities	4.55	2.75	2.15	4.91	0.77	7.12
Total Current Liabilities	144.55	175.85	159.38	128.51	176.02	152.28
Long-Term Debt	300	346	319	350	243.41	336.43
Long-Term Leases	80.7	83.96	87.62	93.77	58.13	67.63
Long-Term Unearned Revenue	2.26	2.73	2.27	1.53	2.09	1.01
Long-Term Deferred Tax Liabilities	11.27	6.17	55.86	88.98	98.99	93.13
Other Long-Term Liabilities	21.56	24.35	10.89	9.39	15.15	41.26
Total Liabilities	560.33	639.06	635.02	672.18	593.79	691.72
Common Stock	1.56	1.55	1.58	1.58	1.57	0.39
Additional Paid-In Capital	946.12	911.09	820.34	721.54	652.47	534.41
Retained Earnings	1,083	1,066	1,325	1,309	1,123	1,085
Comprehensive Income & Other	-64.4	-59.88	-78.32	-66.06	-75.2	-57.29
Total Common Equity	1,966	1,919	2,069	1,967	1,702	1,563
Minority Interest	-	-	-	-	-0.76	8.26
Shareholders' Equity	1,966	1,919	2,069	1,967	1,701	1,571
Total Liabilities & Equity	2,526	2,558	2,704	2,639	2,295	2,263
Total Debt	394.47	444.06	419.54	454.97	326.45	428.93
Net Cash (Debt)	-249.51	-281.87	-266.68	-250.66	-79.42	-197.38
Net Cash Per Share	-1.57	-1.76	-1.66	-1.55	-0.48	-1.22
Filing Date Shares Outstanding	155.81	155.55	158.6	158.17	156.85	156.32
Total Common Shares Outstanding	155.75	154.97	158.22	157.64	156.64	155.82
Working Capital	464.96	432.45	458.04	492.97	429.54	358.32
Book Value Per Share	12.62	12.38	13.08	12.47	10.86	10.03
Tangible Book Value	636.8	572.27	589.11	559.13	348.15	103.94
Tangible Book Value Per Share	4.09	3.69	3.72	3.55	2.22	0.67
Land	8.13	8.15	8.15	9.1	8.57	8.61
Buildings	256.74	254.36	243.86	245.3	229.55	190.66
Machinery	244.19	245.92	215.95	190.02	174.81	149.41
Construction In Progress	20.26	23.42	39.75	15.49	21.73	49.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.